Clinical Trials Logo

N Meningitidis Serogroup B clinical trials

View clinical trials related to N Meningitidis Serogroup B.

Filter by:
  • None
  • Page 1

NCT ID: NCT01323270 Completed - Meningitis Clinical Trials

A Trial to Assess the Safety, Tolerability and Immunogenicity of Repevax and rLP2086 Vaccine When Given Together in Healthy Subjects Aged >=11 to <19 Years.

Start date: March 18, 2011
Phase: Phase 2
Study type: Interventional

This study is to look at a new vaccine that might prevent meningococcal disease, and to look at the safety of the new vaccine as well as how it is tolerated when given together with Repevax. The study will be done in healthy adolescents.